Relatedness of medically important strains of Saccharomyces cerevisiae as revealed by phylogenetics and metabolomics

Yeast

Volumn 25, Issue 7, 2008, Pages 501-512

  MacKenzie, Donald A ^a   Defernez, Marianne ^a   Dunn, Warwick B ^b   Brown, Marie ^b   Fuller, Linda J ^a   Seco de Herrera, Santiago R M ^c   Günther, Andreas ^d   James, Steve A ^a   Eagles, John ^a   Philo, Mark ^a   Goodacre, Royston ^b   Roberts, Ian N ^a  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF EXTREMADURA   (Spain)

^d UNIVERSITY OF APPLIED SCIENCES JENA   (Germany)

Author keywords

AFLP fingerprinting; Direct injection mass spectrometry; GC ToF MS; Saccharomyces boulardii; Saccharomyces cerevisiae; Yeast metabolomics

Indexed keywords

FUMARIC ACID; FUNGAL DNA; GLYCEROPHOSPHATE; INOSITOL; LACTIC ACID; PROBIOTIC AGENT; RIBOSOME DNA; TREHALOSE;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA FINGERPRINTING; DNA FOOTPRINTING; FUNGAL GENETICS; FUNGAL STRAIN; FUNGUS ISOLATION; GAS CHROMATOGRAPHY; GASTROINTESTINAL DISEASE; GENE CLUSTER; GENOTYPE PHENOTYPE CORRELATION; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SACCHAROMYCES BOULARDII; SACCHAROMYCES CEREVISIAE; STRAIN DIFFERENCE; TAXONOMIC IDENTIFICATION; TIME OF FLIGHT MASS SPECTROMETRY; VINICULTURE;

DNA, FUNGAL; DNA, RIBOSOMAL SPACER; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLIC NETWORKS AND PATHWAYS; MYCOLOGICAL TYPING TECHNIQUES; PHYLOGENY; PROBIOTICS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SACCHAROMYCES CEREVISIAE;

SACCHAROMYCES; SACCHAROMYCES BOULARDII; SACCHAROMYCES CEREVISIAE;

EID: 48449101921     PISSN: 0749503X     EISSN: 10970061     Source Type: Journal    
DOI: 10.1002/yea.1601     Document Type: Article

References (61)

1. Abdi H. 2007. Bonferroni and Šidák corrections for multiple comparisons. In Encyclopedia of Measurement and Statistics, Salkind NJ (ed.). Sage: Thousand Oaks, CA; 87-89.
2. Allen J, Davey HM, Broadhurst D, et al. 2003. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nature Biotechnol 21: 692-696.
3. Allen J, Davey HM, Broadhurst D, et al. 2004. Discrimination of modes of action of antifungal substances by use of metabolic footprinting. Appl Environ Microbiol 70: 6157-6165.
4. Azumi M, Goto-Yamamoto N. 2001. AFLP analysis of type strains and laboratory and industrial strains of Saccharomyces sensu stricto and its application to phenetic clustering. Yeast 18: 1145-1154.
5. Barchiesi F, Arzeni D, Compagnucci P, et al. 1998. In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae. Med Mycol 36: 437-440.
6. Barchiesi F, Arzeni D, Fothergill AW, et al. 2000. In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens. Antimicrob Agents Chemother 44: 226-229.
7. Blank LM, Lehmbeck F, Sauer U. 2005. Metabolic-flux and network analysis in fourteen hemiascomycetous yeasts. FEMS Yeast Res 5: 545-558.
8. Borst A. Theelen B, Reinders E, et al. 2003. Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis. J Clin Microbiol 41: 1357-1362.
9. Broadhurst DI, Kell DB. 2006. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2: 171-196.
10. Camacho D. de la Fuente A. Mendes P. 2005. The origin of correlations in metabolomics data Metabolomics 1: 53-63.
11. Castaliuolo I, Riegler MF, Valenick L, et al. 1999. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun 67: 302-307.
12. de Barros Lopes M, Belton JR, Shirley NJ, Ganter PF. 2002. Evidence for multiple interspecific hybridization in Saccharomyces sensu stricto species. FEMS Yeast Res 1: 323-331.
13. de Llanos R, Fernández-Espinar MT. Querol A. 2006a. A comparison of clinical and food Saccharomyces cerevisiae isolates on the basis of potential virulence factors. Antonie van Leeuwenhoek 90: 221-231.
14. de Llanos R. Querol A, Planes AM, Fernandez-Espinar MT. 2004. Molecular characterization of clinical Saccharomyces cerevisiae isolates and their association with non-clinical strains. Syst Appl Microbiol 27: 427-435.
15. de Llano,, R, Querol A, Pemán J, et al. 2006b. Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections. Int J Food Microbiol 110: 286-290.
16. Duarte NC, Herrgård MJ, Palsson BØ. 2004. Reconstruction and validation of Saccharomyces cerevisiae iND750, a fully compartmentalized genome-scale metabolic model. Genome Res 14: 1298-1309.
17. Edwards-Ingram LC, Gent ME, Hoyle DC, et al. 2004. Comparative genomic hybridization provides new insights into the molecular taxonomy of the Saccharomyces sensu stricto complex. Genome Res 14: 1043-1051.
18. Edwards-Ingram L, Gitsham P, Burton N, et al. 2007. Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Appl Environ Microbiol 73: 2458-2467.
19. Fernandes PMB. 2005. How does yeast respond to pressure? Braz J Med Biol Res 38: 1239-1245.
20. Fietto JLR, Araújo RS, Valadão FN, et al. 2004. Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can J Microbiol 50: 615-621.
21. Förster J, Famili I, Fu P, et al. 2003. Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res 13: 244-253.
22. Gaspar ML, Aregullin MA, Jesch SA, et al. 2007. The emergence of yeast lipidomics. Biochim Biophys Acta Mol Cell Biol Lipids 1771: 241-254.
23. Guslandi M. 2006. Are probiotics effective for treating Clostridium difficile disease and antibiotic-associated diarrhea? Nature Clin Pract Gastro Hepatol 3: 606-607.
24. Guo B, Styles CA, Feng Q, Fink GR. 2000. A Saccharomyces gene family involved in invasive growth. cell-cell adhesion, and mating. Proc Natl Acad Sci USA 97: 12158-12163.
25. Hand DJ, Smyth P. Mannila H. (eds). 2001. Principles of Data Mining, 1st edit. MIT Press: Cambridge, MA.
26. Henriques IDS, Aga DS, Mendes P, et al. 2007. Metabolic footprinting: a new approach to identify physiological changes in complex microbial communities upon exposure to toxic chemicals. Environ Sci Technol 41: 3945-3951.
27. Howell KS, Cozzotino D, Bartowsky EJ, et al. 2006. Metabolic profiling as a tool for revealing Saccharomyces interactions during wine fermentation. FEMS Yeast Res 6: 91-101.
28. James SA, Collins MD, Roberts IN. 1996. Use of an rRNA internal transcribed spacer region to distinguish phylogenetically closely related species of the genera Zygosaccharomyces and Torulaspora. Int J Syst Bacteriol 46: 189-194.
29. Junpeng C. 1998. Molecular Phylogenetic Analysis on Some Ascomycetous Spoilage Yeasts. PhD Thesis, University of Reading, UK.
30. Kell DB, Brown M, Davey HM, et al. 2005. Metabolic footprinting and systems biology: the medium is the message. Nature Rev Microbiol 3: 557-565.
31. Kruskal WH, Wallis WA. 1952. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 47: 583-621.
32. Kruskal WH, Wallis WA. 1953. Errata to: Use of ranks in one-criterion variance analysis. J Am Stat Assoc 48: 907-911.
33. Liti G, Peruffo A, James SA, et al. 2005. Inferences of evolutionary relationships from a population survey of LTR-retrotransposons and telomeric-associated sequences in the Saccharomyces sensu stricto complex. Yeast 22: 177-192.
34. Mahalanobis PC. 1936. On the generalized distance in statistics. Proc Natl Inst Sci India 12: 49-55.
35. Massart DL, Vandeginste BGM, Deming SN, et al. 1988. Supervised pattern recognition. In Chemometrics: A Textbook, Vandeginste BGM, Kaufman L (eds). Elsevier: Amsterdam; 387-392.
36. Mas S, Villas-Bôas SG, Hansen ME, et al. 2007. A comparison of direct infusion MS and GC-MS for metabolic footprinting of yeast mutants. Biotechnol Bioeng 96: 1014-1022.
37. McFarland LV. 1996. Saccharomyces boulardii is not Saccharomyces cerevisiae. Clin Infect Dis 22: 200-201.
38. Michell RH, Perera NM, Dove SK. 2003. New insights into the roles of phosphoinositides and inositol polyphosphates in yeast. Biochem Soc Trans 31: 11-15.
39. Montrocher R, Verner M-C, Briolay J, et al. 1998. Phylogenetic analysis of the Saccharomyces cerevisiae group based on polymorphisms of rDNA spacer sequences. Int J Syst Bacteriol 48: 295-303.
40. Muñoz P, Bouza E, Cuenca-Estrella M, et al. 2005. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis 40: 1625-1634.
41. O'Hagan S, Dunn WB, Brown M, et al. 2005. Closed-loop, multiobjective optimization of analytical instrumentation: gas chromatography/time-of-flight mass spectrometry of the metabolomes of human serum and of yeast fermentations. Anal Chem 77: 290-303.
42. Olver WJ, Galloway A, Boswell TC, Russell NH. 2001. Sensitivity of S. cerevisiae in haematology patients. J Hosp Infect 47: 75-75.
43. Olver WJ, James SA, Lennard A, et al. 2002. Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients. J Hosp Infect 52: 268-272.
44. Page RDM. 1996. TreeView: an application to display phylogenetic trees on personal computers. Computer Appl Biosci 12: 357-358.
45. Panni S, Landgraf C, Volkmer-Engert R, et al. 2008. Role of 14-3-3 proteins in the regulation of neutral trehalase in the yeast Saccharomyces cerevisiae. FEMS Yeast Res 8: 53-63.
46. Parrou JL, Jules M, Beltran G, François J. 2005. Acid trehalase in yeasts and filamentous fungi: localization, regulation and physiological function. FEMS Yeast Res 5: 503-511.
47. Pope GA, MacKenzie DA, Defernez M, et al. 2007. Metabolic footprinting as a tool for discriminating between brewing yeasts. Yeast 24: 667-679.
48. Posteraro B, Sanguinetti M, Romano L, et al. 2005. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae. Int J Food Microbiol 103: 295-304.
49. Rice P, Longden I, Bleasby A. 2000. EMBOSS: the European molecular biology open software suite. Trends in Genetics 16: 276-277.
50. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
51. Salonen JH, Richardson MD, Gallacher K, et al. 2000. Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae. J Hosp Infect 45: 293-301.
52. Smith D, Metzgar D, Wills C, Fierer J. 2002. Fatal Saccharomyces cerevisiae aortic graft infection. J Clin Microbiol 40: 2691-2692.
53. Sougioultzis S, Simeonidis S, Bhaskar KR, et al. 2006. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-KB-mediated IL-8 gene expression. Biochem Biophys Res Commun 343: 69-76.
54. Swofford DL, Olsen G. 1990. Phylogenetic reconstruction. In Molecular Systematics, Hillis DM, Moritz C (eds). Sinauer: Sunderland, MA; 411-501.
55. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
56. van der Aa Kühle A, Jespersen L. 2003. The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the Dl/D2 domain of 26S rDNA, the ITSI-5.8S rDNA-ITS2 region and the mitochondrial cytochrome c oxidase II gene. System Appl Microbiol 26: 564-57 1.
57. Vanhoutte T, De Preter V, De Brandt E, et al. 2006. Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl Environ Microbiol 72: 5990-5997.
58. Vanlaere A. 1989. Trehalose, reserve and or stress metabolite. FEMS Microbiol Rev 63: 201-210.
59. Villas-Bôas SG, Noel S, Lane GA, et al. 2006. Extracellular metabolomics: a metabolic footprinting approach to assess fiber degradation in complex media. Anal Biochem 349: 297-305.
60. White TJ, Bruns TD, Lee S, Taylor JW. 1990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In PCR Protocols, Innis M, Gelfand DH, Sninsky JJ, White TJ (eds). Academic Press: San Diego, CA; 315-322.
61. Zabeau M, Vos P. 1993. Selective restriction fragment amplification: a general method for DNA fingerprinting. European Patent No. EP0534858.